8-KEarnings & ResultsExhibits & Filings

BOSTON SCIENTIFIC CORP 8-K Report, Financial Results (Feb 2, 2022)

Filed February 2, 2022For Securities:BSX

Summary

Boston Scientific Corporation (BSX) has filed an 8-K report on February 2, 2022, primarily to furnish their press release announcing financial results for the fourth quarter and full year ended December 31, 2021. This filing serves as the official notification of these results, although the specific financial details are contained within the accompanying press release (Exhibit 99.1), which is not deemed "filed" for regulatory purposes under Section 18 of the Exchange Act. Investors should refer to Exhibit 99.1 for a comprehensive understanding of the company's performance, including key metrics and financial condition as of year-end 2021. The nature of this 8-K filing indicates that the core financial performance information for the period will be found in the press release itself. Therefore, any analysis of BSX's operational results, profitability, revenue streams, or forward-looking statements would require a detailed review of the furnished press release. The filing itself is a procedural step to make these results publicly available.

Key Highlights

  • 1Boston Scientific Corp (BSX) announced its Q4 and full-year 2021 financial results via a press release furnished with this 8-K filing.
  • 2The 8-K was filed on February 2, 2022, with the event date being February 1, 2022.
  • 3The primary purpose of the 8-K is to provide public access to the company's earnings announcement.
  • 4The press release (Exhibit 99.1) contains the detailed financial results and operational performance for the period.
  • 5Information furnished under Item 2.02 of this 8-K, including the press release, is not considered 'filed' for Section 18 of the Exchange Act liability.
  • 6Investors need to consult Exhibit 99.1 for specific financial data and performance analysis.
  • 7The filing includes a Cover Page Interactive Data File (XBRL) for enhanced data accessibility.

Frequently Asked Questions

The specific financial results are detailed in the press release issued by Boston Scientific Corporation on February 2, 2022, which is provided as Exhibit 99.1 with this 8-K filing. Investors should refer to this exhibit for detailed information.

No, the information contained in the press release (Exhibit 99.1) furnished with this 8-K filing is not deemed 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section. It is furnished for informational purposes.

This 8-K filing itself does not contain the specific financial highlights. To understand the key financial results, revenue figures, profitability, and any forward-looking statements, you must review the press release (Exhibit 99.1) that is attached to this filing.

Boston Scientific Corporation announced its financial results for the fourth quarter and full year ended December 31, 2021, in a press release issued on February 2, 2022. This 8-K filing was made on the same date.